The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
A Dose‐Response Study of Testosterone on Sexual Dysfunction and Features of the Metabolic Syndrome Using Testosterone Gel and Parenteral Testosterone Undecanoate
Abstract
ABSTRACT: The objective of this study was to observe the dose‐response effects of testosterone (T) treatment on symptoms of sexual dysfunction and the metabolic syndrome. Two cohorts of elderly men with late‐onset hypogonadism were followed over 9 months. Group 1, consisting of 28 men (mean age, 61 years; mean T level, 2.07 ± 0.50 ng/mL), received long‐acting T undecanoate (TU; 1000 mg); group 2, composed of 27 men (mean age, 60 years; mean T level, 2.24 ± 0.41 ng/mL), received T gel (50 mg/day) for 9 months. In patients treated with T gel, plasma T levels rose from 2.24 ± 0.41 to 2.95 ± 0.52 (statistically significant) at 3 months, 3.49 ± 0.89 (statistically significant) at 6 months, and 3.80 ± 0.73 ng/mL at 9 months (T level at 6 months was compared with T level at 3 months). With TU, plasma T levels rose from 2.08 ± 0.56 to 4.81 ± 0.83 (statistically significant) at 3 months, 5.29 ± 0.91 at 6 months, and 5.40 ± 0.77 ng/mL at 9 months. With TU, the plasma T levels were statistically significantly higher than with T gel With TU, there was a greater improvement in sexual symptoms and in symptoms of the metabolic syndrome. With both treatments, changes in waist circumference correlated with changes in total, low‐density, and high‐density lipoprotein cholesterol. Parameters of safety were not different between the 2 treatments. T administration had a beneficial effect on sexual dysfunction and symptoms of the metabolic syndrome in elderly men. The higher plasma levels of T generated with TU than with T gel were clearly more effective, indicating that there is a T dose‐effect relationship.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In our own studies, signs and symptoms of the metabolic syndrome improved substantially following administration of long-acting testosterone undecanoate (32, 35, 92) and improvements in glycemic control and lipids parallel improvements in body composition.”
From Onset of effects of testosterone treatment and time span until maximum effects are achieved (2011) · cites this paper as [92]
Citations
Cites
Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982
Ford, E. S. (2005) · Diabetes Care · doi:10.2337/diacare.28.11.2745 · Cited by 1,199
Testosterone dose-response relationships in healthy young men
Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Bhasin, D., Berman, N., Chen, X., Yarasheski, K. E., Magliano, L., Dzekov, C., et al. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1172 · Cited by 967
Laaksonen, D. E., Niskanen, L., Punnonen, K., Nyyssönen, K., Tuomainen, T.-P., Valkonen, V.-P., Salonen, R., & Salonen, J. T. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1036 · Cited by 920
Definition of Metabolic Syndrome
Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. J. M. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000111245.75752.c6 · Cited by 739
Wang, C., Cunningham, G., Dobs, A., Iranmanesh, A., Matsumoto, A. M., Snyder, P. J., Weber, T., Berman, N., Hull, L., & Swerdloff, R. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032006 · Cited by 656
Kupelian, V., Page, S. T., Araujo, A. B., Travison, T. G., Bremner, W. J., & McKinlay, J. B. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1326 · Cited by 561
Association of Specific Symptoms and Metabolic Risks with Serum Testosterone in Older Men
Zitzmann, M., Faber, S., & Nieschlag, E. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0401 · Cited by 552
Vermeulen, A. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.5.1821 · Cited by 455
Niskanen, L., Laaksonen, D. E., Punnonen, K., Mustajoki, P., Kaukua, J., & Rissanen, A. (2004) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1462-8902.2004.00335.x · Cited by 275
Research works printed but not linked: 2
- 10.1210/jc.79.4.1173 · DOI · Paper page
- Organization World Health, 1992, Guidelines for the Use of Androgens in Men
Cited by
Sorted by citations
Cornier, M.-A., Dabelea, D., Hernandez, T. L., Lindstrom, R. C., Steig, A. J., Stob, N. R., Van Pelt, R. E., Wang, H., & Eckel, R. H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0024 · Cited by 2,162
Testosterone: a metabolic hormone in health and disease
Kelly, D. M., & Jones, T. H. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0455 · Cited by 612
Kelly, D. M., & Jones, T. H. (2015) · Obesity Reviews · doi:10.1111/obr.12282 · Cited by 487
Kalinchenko, S. Y., Tishova, Y. A., Mskhalaya, G. J., Gooren, L. J., Giltay, E. J., & Saad, F. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03845.x · Cited by 348
Self-citationThe Dark Side of Testosterone Deficiency: I. Metabolic Syndrome and Erectile Dysfunction
Traish, A. M., Guay, A. T., Feeley, R. J., & Saad, F. (2008) · Journal of Andrology · doi:10.2164/jandrol.108.005215 · Cited by 284
Self-citationThe Dark Side of Testosterone Deficiency: III. Cardiovascular Disease
Traish, A. M., Saad, F., Feeley, R. J., & Guay, A. T. (2009) · Journal of Andrology · doi:10.2164/jandrol.108.007245 · Cited by 237
Self-citationOnset of effects of testosterone treatment and time span until maximum effects are achieved
Saad, F., Aversa, A., Isidori, A. M., Zafalon, L., Zitzmann, M., & Gooren, L. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0221 · Cited by 232
Self-citationCorona, G., Mannucci, E., Forti, G., & Maggi, M. (2009) · International Journal of Andrology · doi:10.1111/j.1365-2605.2008.00951.x · Cited by 223
Endocrine Aspects of Male Sexual Dysfunctions
Buvat, J., Maggi, M., Gooren, L., Guay, A. T., Kaufman, J., Morgentaler, A., Schulman, C., Tan, H. M., Torres, L. O., Yassin, A., et al. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01780.x · Cited by 221
Self-citationCorona, G., Giagulli, V. A., Maseroli, E., Vignozzi, L., Aversa, A., Zitzmann, M., Saad, F., Mannucci, E., & Maggi, M. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-0262 · Cited by 217
Self-citationTraish, A. M., Miner, M. M., Morgentaler, A., & Zitzmann, M. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.12.027 · Cited by 206
Vignozzi, L., Morelli, A., Sarchielli, E., Comeglio, P., Filippi, S., Cellai, I., Maneschi, E., Serni, S., Gacci, M., Carini, M., et al. (2011) · Journal of Endocrinology · doi:10.1530/joe-11-0289 · Cited by 187
Self-citationCorona, G., Giagulli, V. A., Maseroli, E., Vignozzi, L., Aversa, A., Zitzmann, M., Saad, F., Mannucci, E., & Maggi, M. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0480-2 · Cited by 185
Self-citationThe effects of testosterone on risk factors for, and the mediators of, the atherosclerotic process
Jones, T. H., & Saad, F. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.04.016 · Cited by 153
Self-citationMetabolic Disorders and Male Hypogonadotropic Hypogonadism
Pivonello, R., Menafra, D., Riccio, E., Garifalos, F., Mazzella, M., de Angelis, C., & Colao, A. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00345 · Cited by 149
Kupelian, V. A., Hayes, F. J., Link, C. L., Rosen, R. C., & McKinlay, J. B. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0054 · Cited by 140
Genomic and non-genomic effects of androgens in the cardiovascular system: clinical implications
Lucas-Herald, A. K., Alves-Lopes, R., Montezano, A. C. I., Ahmed, S. F., & Touyz, R. M. (2017) · Clinical Science · doi:10.1042/cs20170090 · Cited by 138
Why Is Androgen Replacement in Males Controversial?
Cunningham, G. R., & Toma, S. M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0266 · Cited by 111
Traish, A. M., Feeley, R. J., & Guay, A. T. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07305.x · Cited by 115
Alves-Lopes, R., Neves, K. B., Pestana, C. R., Queiroz, A. L., Zanotto, C. Z., Chignalia, A. Z., Lucisano-Valim, Y. M., Silveira, L. R., Curti, C., & Tostes, R. C. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00809.2013 · Cited by 96
Effects of testosterone on Type 2 diabetes and components of the metabolic syndrome
Jones, T. H. (2010) · Journal of Diabetes · doi:10.1111/j.1753-0407.2010.00085.x · Cited by 91
Review: Testosterone and the metabolic syndrome
Muraleedharan, V., & Jones, T. H. (2010) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018810390258 · Cited by 98
Reactive oxygen species: players in the cardiovascular effects of testosterone
Tostes, R. C., Carneiro, F. S., de Carvalho, M. H. C., & Reckelhoff, J. F. (2015) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00392.2014 · Cited by 90
Androgens and the Regulation of Adiposity and Body Fat Distribution in Humans
Tchernof, A., Brochu, D., Maltais‐Payette, I., Mansour, M. F., Marchand, G. B., Carreau, A., & Kapeluto, J. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170009 · Cited by 113
Androgen deficiency and atherosclerosis: The lipid link
Traish, A. M., Abdou, R. Y., & Kypreos, K. E. (2009) · Vascular Pharmacology · doi:10.1016/j.vph.2009.09.003 · Cited by 84
Testosterone and the aging male: To treat or not to treat?
Bain, J. (2010) · Maturitas · doi:10.1016/j.maturitas.2010.01.009 · Cited by 84
Haider, A., Gooren, L. J. G., Padungtod, P., & Saad, F. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1202774 · Cited by 83
Self-citationTestosterone and Vascular Function in Aging
Alves-Lopes, R., Neves, K. B., Carneiro, F. S., & Tostes, R. C. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00089 · Cited by 84
Haider, A., Gooren, L. J., Padungtod, P., & Saad, F. (2009) · Andrologia · doi:10.1111/j.1439-0272.2008.00880.x · Cited by 78
Self-citationInjectable testosterone undecanoate for the treatment of hypogonadism
Corona, G., Maseroli, E., & Maggi, M. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.944896 · Cited by 79
Metabolic syndrome, testosterone deficiency and erectile dysfunction never come alone
Yassin, A. A., Saad, F., & Gooren, L. J. (2008) · Andrologia · doi:10.1111/j.1439-0272.2008.00851.x · Cited by 77
Self-citationSex difference in human diseases: mechanistic insights and clinical implications
Shi, Y., Ma, J., Li, S., Liu, C., Liu, Y., Chen, J., Liu, N., Liu, S., & Huang, H. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01929-7 · Cited by 91
Testosterone and cardiovascular disease: An old idea with modern clinical implications
Traish, A. M., & Kypreos, K. E. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.08.078 · Cited by 73
Kalinchenko, S. Y., Vishnevskiy, E. L., Koval, A. N., Mskhalaya, G. J., & Saad, F. (2008) · The Aging Male · doi:10.1080/13685530801953994 · Cited by 74
Self-citationYu, I.-C. I., Lin, H., Sparks, J. D., Yeh, S., & Chang, C. (2014) · Diabetes · doi:10.2337/db13-1505 · Cited by 71
Consensus statement on diagnosis and clinical management of Klinefelter syndrome
Radicioni, A. F., Ferlin, A., Balercia, G., Pasquali, D., Vignozzi, L., Maggi, M., Foresta, C., & Lenzi, A. (2010) · Journal of Endocrinological Investigation · doi:10.1007/bf03350351 · Cited by 72
Lower urinary-tract symptoms and testosterone in elderly men
Yassin, A. A., El‐Sakka, A. I., Saad, F., & Gooren, L. J. (2008) · World Journal of Urology · doi:10.1007/s00345-008-0284-x · Cited by 64
Self-citationProstate Tissue Androgens: History and Current Clinical Relevance
Marks, L. S., Mostaghel, E. A., & Nelson, P. S. (2008) · Urology · doi:10.1016/j.urology.2008.03.033 · Cited by 64
Ryan, J., & Gajraj, J. (2012) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2011.12.001 · Cited by 60
Gao, Y., Wang, M., Zhang, H., Tan, A., Yang, X., Qin, X., Hu, Y., Zhang, Y., Liao, M., & Mo, Z. (2011) · Urology · doi:10.1016/j.urology.2011.07.1399 · Cited by 54
Relationship between testosterone deficiency and cardiovascular risk and mortality in adult men.
Cattabiani, C., Basaria, S. S., Ceda, G. P., Luci, M., Vignali, A., Lauretani, F., Valenti, G., Volpi, R., & Maggio, M. G. (2012) · PubMed · doi:10.3275/8061 · Cited by 52
Adverse health effects of testosterone deficiency (TD) in men
Traish, A. M. (2014) · Steroids · doi:10.1016/j.steroids.2014.05.010 · Cited by 51
The Emerging Link Between Hypogonadism and Metabolic Syndrome
Guay, A. T. (2009) · Journal of Andrology · doi:10.2164/jandrol.108.006015 · Cited by 50
New Therapy via Targeting Androgen Receptor in Monocytes/Macrophages to Battle Atherosclerosis
Huang, C., Pang, H., Wang, L., Niu, Y., Luo, J., Chang, E. B., Sparks, J. D., Lee, S. O., & Chang, C. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.02804 · Cited by 50
Traish, A. M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-70178-3_22 · Cited by 50
Morales, A., Black, A., Emerson, L., Barkin, J., Kuzmarov, I., & Day, A. (2009) · The Aging Male · doi:10.3109/13685530903294388 · Cited by 46
Permpongkosol, S., Tantirangsee, N., & Ratana-olarn, K. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01994.x · Cited by 44
Comeglio, P., Morelli, A. M., Cellai, I., Vignozzi, L., Sarchielli, E., Filippi, S., Maneschi, E., Corcetto, F., Corno, C., Gacci, M., et al. (2013) · The Prostate · doi:10.1002/pros.22723 · Cited by 42
Cavender, R. K., & Fairall, M. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01513.x · Cited by 41
Kelly, D. M., Sellers, D., Woodroofe, M. N., Jones, T. H., & Channer, K. S. (2012) · Endocrine Research · doi:10.3109/07435800.2012.735307 · Cited by 41
A Possible Relationship Between Testosterone and Lower Urinary Tract Symptoms in Men
Chang, I. H., Oh, S., & Kim, S. C. (2009) · The Journal of Urology · doi:10.1016/j.juro.2009.02.123 · Cited by 41
Late-Onset Hypogonadism Syndrome and Lower Urinary Tract Symptoms
Shigehara, K., & Namiki, M. (2011) · Korean journal of urology · doi:10.4111/kju.2011.52.10.657 · Cited by 39
Testosterone undecanoate in the treatment of male hypogonadism
Edelstein, D. L., & Basaria, S. S. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2010.505920 · Cited by 39
Metabolic and cardiovascular risk factors in Klinefelter syndrome
Spaziani, M., & Radicioni, A. F. (2020) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31792 · Cited by 38
Association between testosterone levels and the metabolic syndrome in adult men
Grosman, H., Rosales, M., Fabre, B. R., Nolazco, C., Mazza, O., Berg, G. A., & Mesch, V. (2014) · The Aging Male · doi:10.3109/13685538.2014.913561 · Cited by 37
Testosterone and metabolic syndrome: The link
Ranabir, S., Kshetrimayum, A., & Reetu, K. (2012) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.94248 · Cited by 38
Hong, D., Kim, Y., Son, E. S., Kim, K.-N., Kim, B.-T., Lee, D.-J., & Kim, K.-M. (2012) · Maturitas · doi:10.1016/j.maturitas.2012.10.016 · Cited by 34
Advances in Testosterone Replacement Therapy
Gooren, L. J. (2008) · Frontiers of hormone research · doi:10.1159/000175842 · Cited by 31
Self-citationGuay, A. T., & Traish, A. M. (2011) · Urologic Clinics of North America · doi:10.1016/j.ucl.2011.02.004 · Cited by 32
Haider, A., Meergans, U., Traish, A. M., Saad, F., Doros, G. D., Lips, P. T. A. M., & Gooren, L. J. (2014) · International Journal of Endocrinology · doi:10.1155/2014/496948 · Cited by 32
Self-citationCarneiro, F. S., Alves-Lopes, R., Neves, K. B., Silva, M., Olivon, V. C., Ruginsk, S. G., Antunes‐Rodrigues, J., Ramalho, L. N. Z., & Tostes, R. C. (2016) · Asian Journal of Andrology · doi:10.4103/1008-682x.173935 · Cited by 30
Traish, A. M., & Johansen, V. (2018) · The World Journal of Men s Health · doi:10.5534/wjmh.180032 · Cited by 32
Male hypogonadism and metabolic syndrome
Naifar, M., Rekik, N. M., Messedi, M., Chaabouni, K., Lahiani, A., Turki, M., Abid, M., Ayedi, F., & Jamoussi, K. (2014) · Andrologia · doi:10.1111/and.12305 · Cited by 29
Androgens and male aging: current evidence of safety and efficacy
Gooren, L. J. (2010) · Asian Journal of Andrology · doi:10.1038/aja.2010.4 · Cited by 29
Self-citationAndrogens and the Regulation of Adiposity and Body Fat Distribution in Humans
Tchernof, A., Brochu, D., Maltais‐Payette, I., Mansour, M. F., Marchand, G. B., Carreau, A., & Kapeluto, J. (2018) · Comprehensive physiology · doi:10.1002/j.2040-4603.2018.tb00043.x · Cited by 27
Outcomes of testosterone therapy in men with testosterone deficiency (TD): Part II
Traish, A. M. (2014) · Steroids · doi:10.1016/j.steroids.2014.05.004 · Cited by 27
Orabi, H., Albersen, M., & Lue, T. F. (2011) · International Journal of Impotence Research · doi:10.1038/ijir.2011.14 · Cited by 27
Constantinou, C., Mpatsoulis, D., Νάτσος, Α., Πετροπούλου, Π.-Ι., Zvintzou, E., Traish, A. M., Voshol, P. J., Karagiannides, I., & Kypreos, K. E. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m050047 · Cited by 27
Testosterone Deficiency and Nocturia: A Review
Shigehara, K., Izumi, K., Mizokami, A., & Namiki, M. (2017) · The World Journal of Men s Health · doi:10.5534/wjmh.2017.35.1.14 · Cited by 26
Alwani, M. M., Yassin, A. A., Talib, R. A., Al-Qudimat, A. R., Aboumarzouk, O. M., Al‐Zoubi, R. M., Saad, F., Haider, K. S., & Ansari, A. A. (2021) · Vascular Health and Risk Management · doi:10.2147/vhrm.s309714 · Cited by 25
Self-citationWada, N., Kita, M., Hashizume, K., Matsumoto, S., & Κakizaki, H. (2013) · Neurourology and Urodynamics · doi:10.1002/nau.22349 · Cited by 21
Testosterone, Endothelial Health, and Erectile Function
Castela, Â., Vendeira, P., & Costa, C. (2011) · ISRN Endocrinology · doi:10.5402/2011/839149 · Cited by 21
Dogan, B. A., Karakılıç, E., Tuna, M. M., Arduç, A., Berker, D. S., & Güler, S. (2014) · Clinical Endocrinology · doi:10.1111/cen.12617 · Cited by 18
Gooren, L. J. (2008) · Frontiers of hormone research · doi:10.1159/000176045 · Cited by 17
Self-citationKim, J. H., Doo, S. W., Yun, J. H., & Yang, W. J. (2014) · Urology · doi:10.1016/j.urology.2014.05.019 · Cited by 17
Androgens are Fundamental in the Maintenance of Male Sexual Health
Morales, Á. (2011) · Current Urology Reports · doi:10.1007/s11934-011-0202-4 · Cited by 16
Lim, C. A.-R., Nightingale, T. E., Elliott, S., & Krassioukov, A. V. (2019) · Spinal Cord · doi:10.1038/s41393-019-0404-z · Cited by 16
Short term testosterone replacement therapy improves libido and body composition
Júnior, E. S. D. A., Clapauch, R., & Buksman, S. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000800014 · Cited by 16
Androgen modulates cardiac fibrosis contributing to gender differences on heart failure
Chung, C., Kao, Y., Chen, Y., & Chen, Y.-J. (2013) · The Aging Male · doi:10.3109/13685538.2012.754008 · Cited by 13
Enatsu, N., Chiba, K., Sumii, K., Fukuda, T., Okada, K., Matsushita, K., & Fujisawa, M. (2016) · Andrology · doi:10.1111/andr.12297 · Cited by 12
Bang, W. J., Kim, H., Oh, C. Y., Jo, J. K., Cho, J. S., & Shim, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-21963-1 · Cited by 11
Dimitropoulos, K., Verze, P., den Broeck, T. V., Salonia, A., Yuan, C. Y., Konstantinos Hatzimouratidis, A., & Dohle, G. R. (2019) · International Journal of Impotence Research · doi:10.1038/s41443-019-0131-1 · Cited by 11
Clomiphene citrate: the changing landscape
Gupta, M. C., & Khanna, J. (2018) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20183011 · Cited by 13
Mirghani, S. J., Agha-Alinejad, H., Azarbayjani, M. A., Mazidi, A., & Mirghani, S. A. (2014) · Baltic Journal of Health and Physical Activity · doi:10.2478/bjha-2014-0001 · Cited by 9
Current and emerging testosterone therapies for male hypogonadism
Kaminetsky, J. C., & Wynia, B. (2015) · Research and Reports in Endocrine Disorders · doi:10.2147/rred.s46193 · Cited by 9
Die Therapie des Hypogonadismus des Mannes
Zitzmann, M. (2008) · Der Internist · doi:10.1007/s00108-008-2108-x · Cited by 9
Prohibitin: A hypothetical target for sex-based new therapeutics for metabolic and immune diseases
Mishra, S., & Nyomba, B. L. G. (2019) · Experimental Biology and Medicine · doi:10.1177/1535370219828362 · Cited by 13
Molecular effects of supraphysiological doses of doping agents on health
Imperlini, E., Mancini, A., Alfieri, A., Martone, D., Caterino, M., Orrù, S., & Buono, P. (2015) · Molecular BioSystems · doi:10.1039/c5mb00030k · Cited by 7
Updates on androgen replacement therapy and lower urinary tract symptoms: a narrative review
Al‐Zoubi, R. M., Alwani, M. M., Aboumarzouk, O. M., Elaarag, M., Al-Qudimat, A. R., Ojha, L. K., & Yassin, A. A. (2022) · The Aging Male · doi:10.1080/13685538.2022.2118253 · Cited by 7
Self-citationSaad, F., Haider, A., Giltay, E. J., & Gooren, L. J. (2011) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci.2010.081 · Cited by 7
Self-citationShaheen, D. (2014) · Advances in Biochemistry · doi:10.11648/j.ab.20140202.12 · Cited by 7
Effects of testosterone replacement on glucose and lipid metabolism
Errazuriz, I., Dube, S., Basu, A., & Basu, R. (2015) · Cardiovascular Endocrinology · doi:10.1097/xce.0000000000000061 · Cited by 6
Chuang, S., Liu, K.-M., Lee, Y., Lin, R., Chang, C.-Y., Wu, W., Chang, W., Levin, R. M., & Juan, Y. (2013) · The Journal of Sexual Medicine · doi:10.1111/jsm.12104 · Cited by 6
Haider, A., Gooren, L. J., Padungtod, P., & Saad, F. (2009) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci.2010.002 · Cited by 5
Self-citationTestosterone and estradiol in men with acute ischemic stroke: A North Indian case control
Bhadra, J., Seth, S., Kulshrestha, M. R., Dhupper, V., Aggarwal, H. K., & Sen, J. (2022) · Current Journal of Neurology · doi:10.18502/cjn.v20i4.8345 · Cited by 5
Metabolic Syndrome and Hypogonadism
Wespes, E. (2013) · European Urology Supplements · doi:10.1016/j.eursup.2013.03.003 · Cited by 5
Cai, L., Xie, H., Li, W., Chen, C., Li, T., Xu, L., Mao, Y., Liang, J., Wen, J., & Chen, G. (2025) · Endocrine · doi:10.1007/s12020-025-04199-7 · Cited by 4
Alidu, H. W., Amidu, N., Owiredu, W. K. B. A., Gyasi-Sarpong, C. K., Bawah, A. T., Dapare, P. P. M., & Prempeh, E. B. A. (2017) · Advances in Sexual Medicine · doi:10.4236/asm.2017.72008 · Cited by 4
Gooren, L. J. (2008) · Journal of Men s Health · doi:10.1016/j.jomh.2008.04.002 · Cited by 4
Self-citationPhase II drugs currently being investigated for the treatment of hypogonadism
Udedibia, E., & Kaminetsky, J. C. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.948151 · Cited by 3
Metadata
- Authors
- Saad, F., Gooren, L. J., Haider, A., & Yassin, A.
- Affiliations
- Gulf Medical University (AE)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Corresponding author
- Saad, Farid
- Venue
- Journal of Andrology
- Publisher
- Wiley
- Published
- 2008-01-02
- Volume
- 29
- Issue
- 1
- Pages
- 102-105
- ISSN
- 0196-3635 (ISSN-L)
- 1939-4640
- OpenAlex
- W2081710331
- Cited by
- 132
- References
- 22
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 2 · 2022: 4 · 2021: 1 · 2020: 2 · 2019: 6 · 2018: 5 · 2017: 5 · 2016: 4 · 2015: 6 · 2014: 17 · 2013: 7 · 2012: 8
- FWCI
- 11.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Andrology (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- testosterone, testosterone undecanoate, testosterone gel, andropause, sexual dysfunction, metabolic syndrome, dose-response relationship, older men, plasma testosterone, waist circumference, lipoproteins, testosterone replacement therapy
- MeSH terms
- Administration, Topical, Body Weight, Dose-Response Relationship, Drug, Gels, Humans, Injections, Cholesterol, HDL, Cholesterol, LDL, Male, Middle Aged, Sexual Dysfunction, Physiological, Testosterone, Triglycerides, Cohort Studies, Metabolic Syndrome, Testosterone Congeners
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
